1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

Regional Conference on Malignant Mesothelioma: Destination New York

NewYorkSkyline

All of us at the Meso Foundation have been very aware of the need mesothelioma patients and families have to connect with others facing similar challenges, and learn about their disease and its treatment options.

For this reason, for the second consecutive year, we are organizing a regional conference taking place in New York City.

On Friday, September 27, at 9 AM, please join us at the Harvard Club for this one-day conference on malignant mesothelioma for patients, their families, doctors, and others wishing to learn more about this disease. The conference is supported by an educational grant from Levy Phillips & Konigsberg, LLP.

We put together an impressive line-up of mesothelioma experts from the New York area who will discuss topics including standard treatments, ongoing research, environmental/occupational exposure risk, and legal implications. Read the agenda here. 

[standout-css3-button cssclass=”button-twitter” href=”https://www.curemeso.org/site/c.kkLUJ7MPKtH/b.8252409/k.82EF/New_York_Conference_Knowledge_Is_Hope.htm”]
Register[/standout-css3-button]

You can watch below our last year’s conference:

[youlist pid=”PLofDCGykXdodptU0Qsh2dTyFqBRTR2Wxb”]

The cost to register is $25 per person (includes all sessions, breakfast and lunch). You may register by visiting curemeso.org/knowledge or by calling the Meso Foundation at (703) 879-3797. Registration fees will be donated back to the Meso Foundation. Availability is limited. You must register before our deadline of September 10.

If you are traveling to the conference and need a hotel room, we put together a list of hotels available nearby. Due to the Clinton Global Initiative annual meeting taking place around the same time as our conference, the hotels near the Harvard Club and throughout New York City could be very expensive, so make sure you book early.

Also...

In Other News

Share:

Facebook
Twitter
LinkedIn